Related Experiment Video
Updated: May 27, 2026

04:43
Targeted Knockdown of Genes in the Choroid Plexus
Published on: June 16, 2023
α2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2
Jacque P K Ip1, Lei Shi, Yu Chen
1Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Nature Neuroscience
|December 6, 2011
Summary
α2-chimaerin is crucial for guiding brain neuron migration and function. Its disruption leads to developmental defects and increased seizure susceptibility in mice, revealing a new mechanism for neurodevelopmental disorders.
Area of Science:
- Neuroscience
- Developmental Biology
- Molecular Biology
Background:
- Disrupted cortical neuronal migration is linked to epilepsy and developmental delays.
- The molecular basis of how early cortical development issues cause neurological symptoms remains unclear.
Purpose of the Study:
- To identify key molecular regulators of cortical neuronal migration and function.
- To elucidate the role of α2-chimaerin in early brain development and its connection to neurological disorders.
Main Methods:
- Utilized in utero gene suppression in mice to study α2-chimaerin function.
- Analyzed neuronal migration patterns and cortical circuitry.
- Investigated the interaction between α2-chimaerin and CRMP-2.
Main Results:
- Suppression of α2-chimaerin halted neuronal migration, causing ectopic neuron accumulation.
- Mice with migration defects exhibited excitation-inhibition imbalance and heightened seizure susceptibility.
- α2-chimaerin modulates CRMP-2 activity, influencing neuronal migration and bipolar transition.
Conclusions:
- α2-chimaerin is a critical regulator of cortical neuronal migration and cerebral cortex function.
- This study reveals a novel α2-chimaerin-dependent pathway impacting brain development.
- Findings offer insights into the pathogenesis of seizure-related neurodevelopmental disorders.
Related Concept Videos
Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Catenins
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...

